About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Phase III Trial
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Phosphagenics Provides Update on TPM Propofol Development Program
November 9, 2017
Click here to read more
Post navigation
Previous Post
Phosphagenics Mylan Arbitration Hearing Concluded
Next Post
Phosphagenics Signs a Multinational License for TPM® in Personal Care Products
Related Posts
Phosphagenics Restructures
October 12, 2015
Phosphagenics Signs a Multinational License for TPM® in Personal Care Products
December 4, 2017
First Patient Dosed in Phase III Insomnia Trial
May 16, 2024
May 16, 2024